|
1. Biologie
|
|
|
|
|
|
3.1 Tabac
|
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
5. Traitements
|
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
5.2.2 Pharma - Fusions & Acquisitions
|
|
|
|
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.10 Politiques
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
Libertarians score big victory in 'right-to-try' drug bill [Politico]
|
|
|
|
|
|
It’s
hard for lawmakers to say no to “hope.” “Opposing right-to-try laws is
akin to opposing motherhood, apple pie, and the American flag; you just
don’t do it and expect to be re-elected,” David Gorski, an oncologist at
Wayne State University, wrote in his blog on science-based medicine.
|
|
|
|
|
|
|
Senate Passes F.D.A. Funding and ‘Right to Try’ Drug Bills [NY Times]
|
|
|
|
|
|
The
bill would establish national standards and rules to help channel drugs
still under development to terminally ill patients. It would also
shield pharmaceutical companies and doctors from some of the legal risks
of providing drugs that have not been approved by the agency.
|
|
|
|
|
|
|
6.11 Patients
|
|
|
|
6.6 Publications
|
|
|
|
6.9 Controverses
|
|
|